Skip to main content

Vascular Access—Functional Arteriovenous Fistula (AVF) or AV Graft or Evaluation for Placement

CBE ID
0251
1.4 Project
Renal
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Fall 2019
Is Under Review
No
1.3 Measure Description

Percentage of end stage renal disease (ESRD) patients aged 18 years and older receiving hemodialysis during the 12-month reporting period and on dialysis >90 days who:

1. have a functional autogenous AVF (defined as two needles used or a single-needle device [NOT one needle used in a two-needle device]) (computed and reported separately);

2. have a functional AV graft (computed and reported separately); or

3. have a catheter, but have been seen/evaluated by a vascular surgeon, other surgeon qualified in the area of vascular access, or interventional nephrologist trained in the primary placement of vascular access for a functional autogenous AVF or AV graft at least once during the 12-month reporting period (computed and reported separately).

Reporting should be stratified by incident versus prevalent patients, as defined by USRDS.

    • 1.14 Numerator

      Number of patients from the denominator who:

      1. have a functional autogenous AVF (defined as two needles used or a single-needle device) (computed and reported separately); or

      2. have a functional AV graft (computed and reported separately); or

      3. have a catheter but have been seen/evaluated by a vascular surgeon, other surgeon qualified in the area of vascular access, or interventional nephrologist trained in the primary placement of vascular access for a functional autogenous AVF (defined as two needles used or a single needle device) or AV graft at least once during the 12-month reporting period (computed and reported separately).

      Reporting should be stratified by incident versus prevalent patients, as defined by USRDS.

    • 1.15 Denominator

      All ESRD patients aged 18 years and older receiving hemodialysis during the 12-month reporting period and on dialysis for greater than 90 days.

      This measure includes both in-center and home hemodialysis patients.

    • Exclusions

      None.

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Renal Fall Cycle 2019
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      Kidney Care Quality Alliance
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      © 2015 Kidney Care Quality Alliance. All Rights Reserved.